Global Peptide and Anticoagulant Drug Market Size study, by by product (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, Others) by Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis, Cardiology, Gynaecology, Other Applications) and Regional Forecasts 2021-2027

BIZ4899676
200 Pages
January 2022
Pharmaceuticals

Download Sample Get Discount

Global Peptide and Anticoagulant Drug Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 3.3% over the forecast period 2021-2027. Peptides are a specific type of medicine made up of proteins called amino acids that are linked together by a peptide bond. Peptides therapeutics are known to play a significant part in any biological process, and as a result, they are in great demand for pharmacological usage. Whereas, anticoagulants are a family of therapeutics that aid in the reduction or prevention of blood clotting. The Peptide and Anticoagulant Drug market is driven by key factors such as growing investments in research and development of novel drugs and rising prevalence of cancer and metabolic disorders. Furthermore, increased healthcare costs, an ageing population, and the rise of chronic illnesses propel the peptide and anticoagulant drugs market. According to GLOBOCAN cancer statistics predictions of incidence and mortality worldwide for the year 2020, a total of 19.3 million new cancer cases were detected globally, with 9.9 million deaths due to cancer, according to an article published by the National Center for Biotechnology Information. In addition, by 2040, the number of new cancer cases worldwide is predicted to reach 28.4 million. Chronic illnesses, such as cardiovascular diseases, cancer and diabetes are the main global causes of mortality and disability, according to important facts issued by the World Health Organization (WHO) in April 2021. However, high cost of developing drugs impedes the growth of the market over the forecast period of 2021-2027.

The geographical regions considered for the global Peptide and Anticoagulant Drug market analysis include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is leading the market owing to significant factors such as increasing prevalence of cardiovascular disorders and high demand for peptide and anticoagulants drugs. However, Asia Pacific is projected to record the fastest growth in the upcoming years due to increasing tobacco use within the population and rising prevalence of cancer in the forecast years 2021-2027.

Major market players included in this report are:

Boehringer Ingelheim International GmbH

Bristol-Myers Squibb Company

Johnson & Johnson

Novartis AG

Daiichi Sankyo Company

Novo Nordisk A/S

EVER Pharma

Bayer AG

Pfizer Inc.

Amgen Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Hormonal

Antibiotic

ACE Inhibitor

Antifungal

Others

By Application:

Diabetes

Infectious Diseases

Cancer

Osteoporosis

Cardiology

Gynecology

Other Application

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Peptide and Anticoagulant Drug Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Global Peptide and Anticoagulant Drug Market, by Region, 2019-2027 (USD Billion)

1.2.2. Global Peptide and Anticoagulant Drug Market, by Product, 2019-2027 (USD Billion)

1.2.3. Global Peptide and Anticoagulant Drug Market, by Application, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Peptide and Anticoagulant Drug Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Peptide and Anticoagulant Drug Market Dynamics

3.1. Peptide and Anticoagulant Drug Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Growing Investments in Research and Development of Novel Drugs

3.1.1.2. Rising Prevalence of Cancer and Metabolic Disorders

3.1.2. Market Challenges

3.1.2.1. Stringent Government Regulations

3.1.2.2. High Cost of Developing Drugs

3.1.3. Market Opportunities

3.1.3.1. Technological Advancements

Chapter 4. Global Peptide and Anticoagulant Drug Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Peptide and Anticoagulant Drug Market, by Product

6.1. Market Snapshot

6.2. Global Peptide and Anticoagulant Drug Market by Product, Performance - Potential Analysis

6.3. Global Peptide and Anticoagulant Drug Market Estimates & Forecasts by Product, 2018-2027 (USD Billion)

6.4. Peptide and Anticoagulant Drug Market, Sub Segment Analysis

6.4.1. Hormonal

6.4.2. Antibiotic

6.4.3. ACE Inhibitor

6.4.4. Antifungal

6.4.5. Others

Chapter 7. Global Peptide and Anticoagulant Drug Market, by Application

7.1. Market Snapshot

7.2. Global Peptide and Anticoagulant Drug Market by Application, Performance – Potential Analysis

7.3. Global Peptide and Anticoagulant Drug Market Estimates & Forecasts by Application, 2018-2027 (USD Billion)

7.4. Peptide and Anticoagulant Drug Market, Sub Segment Analysis

7.4.1. Diabetes

7.4.2. Infectious Diseases

7.4.3. Cancer

7.4.4. Osteoporosis

7.4.5. Cardiology

7.4.6. Gynecology

7.4.7. Other Applications

Chapter 8. Global Peptide and Anticoagulant Drug Market, Regional Analysis

8.1. Peptide and Anticoagulant Drug Market, Regional Market Snapshot

8.2. North America Peptide and Anticoagulant Drug Market

8.2.1. U.S. Peptide and Anticoagulant Drug Market

8.2.1.1. Product breakdown estimates & forecasts, 2018-2027

8.2.1.2. Application breakdown estimates & forecasts, 2018-2027

8.2.2. Canada Peptide and Anticoagulant Drug Market

8.3. Europe Peptide and Anticoagulant Drug Market Snapshot

8.3.1. U.K. Peptide and Anticoagulant Drug Market

8.3.2. Germany Peptide and Anticoagulant Drug Market

8.3.3. France Peptide and Anticoagulant Drug Market

8.3.4. Spain Peptide and Anticoagulant Drug Market

8.3.5. Italy Peptide and Anticoagulant Drug Market

8.3.6. Rest of Europe Peptide and Anticoagulant Drug Market

8.4. Asia-Pacific Peptide and Anticoagulant Drug Market Snapshot

8.4.1. China Peptide and Anticoagulant Drug Market

8.4.2. India Peptide and Anticoagulant Drug Market

8.4.3. Japan Peptide and Anticoagulant Drug Market

8.4.4. Australia Peptide and Anticoagulant Drug Market

8.4.5. South Korea Peptide and Anticoagulant Drug Market

8.4.6. Rest of Asia Pacific Peptide and Anticoagulant Drug Market

8.5. Latin America Peptide and Anticoagulant Drug Market Snapshot

8.5.1. Brazil Peptide and Anticoagulant Drug Market

8.5.2. Mexico Peptide and Anticoagulant Drug Market

8.6. Rest of The World Peptide and Anticoagulant Drug Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Boehringer Ingelheim International GmbH

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Bristol-Myers Squibb Company

9.2.3. Johnson & Johnson

9.2.4. Novartis AG

9.2.5. Daiichi Sankyo Company

9.2.6. Novo Nordisk A/S

9.2.7. EVER Pharma

9.2.8. Bayer AG

9.2.9. Pfizer Inc.

9.2.10. Amgen Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global Peptide and Anticoagulant Drug market, report scope

TABLE 2. Global Peptide and Anticoagulant Drug market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Peptide and Anticoagulant Drug market estimates & forecasts by Product 2018-2027 (USD Billion)

TABLE 4. Global Peptide and Anticoagulant Drug market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 5. Global Peptide and Anticoagulant Drug market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Peptide and Anticoagulant Drug market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Peptide and Anticoagulant Drug market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Peptide and Anticoagulant Drug market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Peptide and Anticoagulant Drug market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Peptide and Anticoagulant Drug market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Peptide and Anticoagulant Drug market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Peptide and Anticoagulant Drug market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Peptide and Anticoagulant Drug market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Peptide and Anticoagulant Drug market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. U.S. Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 17. U.S. Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. Canada Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Canada Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. Canada Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. UK Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. UK Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. UK Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Germany Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Germany Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Germany Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. RoE Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. RoE Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. RoE Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. China Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. China Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. China Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. India Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. India Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. India Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Japan Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Japan Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Japan Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. RoAPAC Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. RoAPAC Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. RoAPAC Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. Brazil Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. Brazil Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Brazil Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Mexico Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. Mexico Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Mexico Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. RoLA Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. RoLA Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. RoLA Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Row Peptide and Anticoagulant Drug market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Row Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Row Peptide and Anticoagulant Drug market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. List of secondary sources, used in the study of global Peptide and Anticoagulant Drug market

TABLE 55. List of primary sources, used in the study of global Peptide and Anticoagulant Drug market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Peptide and Anticoagulant Drug Market Size study, by by product (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, Others) by Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis, Cardiology, Gynaecology, Other Applications) and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara